Zyprexa Patent Verdict Coming April 14
This article was originally published in The Pink Sheet Daily
Executive Summary
Timing of the Indianapolis court's verdict suggests the outcome could be favorable for Lilly. The announcement comes a week after a federal appeals court rescinded a ruling on a Paxil patent that could have aided generic companies' challenges to the olanzapine patent.